TRxADE HEALTH (MEDS) Stock Price, News & Analysis

Company Overview

TRxADE Health, Inc. operates a web-based pharmaceutical marketplace designed to streamline drug procurement for independent pharmacies, healthcare providers and long-term care facilities across the United States. Through its proprietary platform, the company enables registered pharmacies to source FDA‐approved branded and generic medications directly from wholesalers and manufacturers, improving inventory management and cost efficiency. The marketplace incorporates real-time pricing, order tracking and digital invoicing, allowing clients to compare offers and secure competitive rates in a single interface.

In addition to its B2B marketplace, TRxADE Health offers patient‐facing services under the MEDS™ brand. These include telehealth consultations, online prescription transfers and fulfillment through licensed pharmacy partners. Members gain access to discounted pricing on a broad range of medications, including specialty and chronic care therapies, while benefiting from home delivery or in‐store pickup options. The integrated model aims to enhance adherence, lower out-of-pocket expenses and expand access to prescribed treatments.

The company was founded in 2011 and is headquartered in Neptune, New Jersey. TRxADE Health completed its initial public offering in 2017 and trades on the NASDAQ under the ticker symbol MEDS. Since its inception, the firm has grown its network to include hundreds of pharmacy locations and dozens of wholesale partners, serving customers in all fifty states. Over time, the company has pursued strategic alliances to expand its service offerings and explore opportunities in adjacent markets, such as pharmacy benefit management and digital health solutions.

Under the leadership of Chairman and CEO Sudarshan Khanna, TRxADE Health’s management team brings decades of experience in healthcare technology, pharmacy operations and regulatory compliance. The company’s board features industry veterans with backgrounds in pharmaceutical distribution, health IT and finance. Together, they continue to refine the platform’s capabilities, pursue strategic growth initiatives and enhance value for both pharmacy clients and members of the consumer-facing network.

Key Stats

• Today's Range: $1.55 to $1.67
• 50-Day Range: $0.84 to $1.64
• 52-Week Range: $3.69 to $44.56
• Volume: 168,138 shs
• Average Volume: 207,831 shs
• Market Capitalization: $2.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MEDS Stock Analysis - Frequently Asked Questions

How have MEDS shares performed this year?

TRxADE HEALTH's stock was trading at $6.20 on January 1st, 2025. Since then, MEDS shares have decreased by 73.5% and is now trading at $1.64.

How were TRxADE HEALTH's earnings last quarter?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) issued its quarterly earnings results on Sunday, October, 24th. The company reported ($2.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.95) by $0.45. The firm earned $2.55 million during the quarter, compared to analyst estimates of $1.94 million. TRxADE HEALTH had a negative trailing twelve-month return on equity of 196.79% and a negative net margin of 149.81%.

When did TRxADE HEALTH's stock split?

Shares of TRxADE HEALTH reverse split on Thursday, June 22nd 2023.The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of TRxADE HEALTH?

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of TRxADE HEALTH own?

Based on aggregate information from My MarketBeat watchlists, some other companies that TRxADE HEALTH investors own include NVIDIA (NVDA), Communications Systems (JCS), Biora Therapeutics (BIOR), Paratek Pharmaceuticals (PRTK), Citius Pharmaceuticals (CTXR), Meta Platforms (META) and Advanced Micro Devices (AMD).

Company Calendar

• Last Earnings: 10/24/2021
• Today: 7/11/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Drugs, proprietaries, & sundries
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:MEDS
• CIK: 1382574
• Web: www.trxade.com
• Phone: (800) 261-0281
• Fax: 800-265-6932
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$17.84 million
• Net Margins: -149.81%
• Pretax Margin: -250.53%
• Return on Equity: -196.79%
• Return on Assets: -112.21%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.18
• Quick Ratio: 4.18

Sales & Book Value

• Annual Sales: $7.45 million
• Price / Sales: 0.31
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.45 per share
• Price / Book: 3.64

Miscellaneous

• Outstanding Shares: 1,406,000
• Free Float: 725,000
• Market Cap: $2.31 million
• Optionable: Not Optionable
• Beta: 2.32